410 related articles for article (PubMed ID: 29099761)
1. The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling.
Cochet F; Peri F
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099761
[TBL] [Abstract][Full Text] [Related]
2. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway.
Zughaier SM; Tzeng YL; Zimmer SM; Datta A; Carlson RW; Stephens DS
Infect Immun; 2004 Jan; 72(1):371-80. PubMed ID: 14688118
[TBL] [Abstract][Full Text] [Related]
3. Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.
Di Lorenzo F; Kubik Ł; Oblak A; Lorè NI; Cigana C; Lanzetta R; Parrilli M; Hamad MA; De Soyza A; Silipo A; Jerala R; Bragonzi A; Valvano MA; Martín-Santamaría S; Molinaro A
J Biol Chem; 2015 Aug; 290(35):21305-19. PubMed ID: 26160169
[TBL] [Abstract][Full Text] [Related]
4. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
Front Immunol; 2021; 12():631797. PubMed ID: 33815382
[TBL] [Abstract][Full Text] [Related]
5. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
Park BS; Song DH; Kim HM; Choi BS; Lee H; Lee JO
Nature; 2009 Apr; 458(7242):1191-5. PubMed ID: 19252480
[TBL] [Abstract][Full Text] [Related]
6. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
7. Recognition of lipid A variants by the TLR4-MD-2 receptor complex.
Maeshima N; Fernandez RC
Front Cell Infect Microbiol; 2013; 3():3. PubMed ID: 23408095
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways.
Zamyatina A; Heine H
Front Immunol; 2020; 11():585146. PubMed ID: 33329561
[TBL] [Abstract][Full Text] [Related]
9. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
Mishra V; Pathak C
J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
[TBL] [Abstract][Full Text] [Related]
11. The molecular mechanism of species-specific recognition of lipopolysaccharides by the MD-2/TLR4 receptor complex.
Oblak A; Jerala R
Mol Immunol; 2015 Feb; 63(2):134-42. PubMed ID: 25037631
[TBL] [Abstract][Full Text] [Related]
12. Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4.
Zimmer SM; Zughaier SM; Tzeng YL; Stephens DS
Glycobiology; 2007 Aug; 17(8):847-56. PubMed ID: 17545685
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide expression profiling and mutagenesis studies reveal that lipopolysaccharide responsiveness appears to be absolutely dependent on TLR4 and MD-2 expression and is dependent upon intermolecular ionic interactions.
Meng J; Gong M; Björkbacka H; Golenbock DT
J Immunol; 2011 Oct; 187(7):3683-93. PubMed ID: 21865549
[TBL] [Abstract][Full Text] [Related]
14. Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.
Mattis DM; Chervin AS; Ranoa DR; Kelley SL; Tapping RI; Kranz DM
Mol Immunol; 2015 Dec; 68(2 Pt A):203-12. PubMed ID: 26320630
[TBL] [Abstract][Full Text] [Related]
15. MD-2: the Toll 'gatekeeper' in endotoxin signalling.
Gangloff M; Gay NJ
Trends Biochem Sci; 2004 Jun; 29(6):294-300. PubMed ID: 15276183
[TBL] [Abstract][Full Text] [Related]
16. Myeloid differentiation 2 as a therapeutic target of inflammatory disorders.
Park SH; Kim ND; Jung JK; Lee CK; Han SB; Kim Y
Pharmacol Ther; 2012 Mar; 133(3):291-8. PubMed ID: 22119168
[TBL] [Abstract][Full Text] [Related]
17. Functional activity of MD-2 polymorphic variant is significantly different in soluble and TLR4-bound forms: decreased endotoxin binding by G56R MD-2 and its rescue by TLR4 ectodomain.
Vasl J; Prohinar P; Gioannini TL; Weiss JP; Jerala R
J Immunol; 2008 May; 180(9):6107-15. PubMed ID: 18424732
[TBL] [Abstract][Full Text] [Related]
18. A Thermodynamic Funnel Drives Bacterial Lipopolysaccharide Transfer in the TLR4 Pathway.
Huber RG; Berglund NA; Kargas V; Marzinek JK; Holdbrook DA; Khalid S; Piggot TJ; Schmidtchen A; Bond PJ
Structure; 2018 Aug; 26(8):1151-1161.e4. PubMed ID: 29779787
[TBL] [Abstract][Full Text] [Related]
19. Structural variants of Salmonella Typhimurium lipopolysaccharide induce less dimerization of TLR4/MD-2 and reduced pro-inflammatory cytokine production in human monocytes.
Aldapa-Vega G; Moreno-Eutimio MA; Berlanga-Taylor AJ; Jiménez-Uribe AP; Nieto-Velazquez G; López-Ortega O; Mancilla-Herrera I; Cortés-Malagón EM; Gunn JS; Isibasi A; Wong-Baeza I; López-Macías C; Pastelin-Palacios R
Mol Immunol; 2019 Jul; 111():43-52. PubMed ID: 30959420
[TBL] [Abstract][Full Text] [Related]
20. Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica.
Hajjar AM; Ernst RK; Fortuno ES; Brasfield AS; Yam CS; Newlon LA; Kollmann TR; Miller SI; Wilson CB
PLoS Pathog; 2012; 8(10):e1002963. PubMed ID: 23071439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
